| KRN 633 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹唑啉基)氧基]苯基]-N'-丙基脲 |
286370-15-8 |
| GEN6776 |
GEN6776 |
2009273-71-4 |
| 2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethyl-N-[4-(2-methylphenyl)-6-(4-methylpiperazin-1-yl)pyridin-3-yl]propanamide |
奈妥吡坦 |
290297-26-6 |
| BAY 41-2272 |
BAY 41-2272 |
256376-24-6 |
| UK-371804 hydrochloride |
UK-371,804 HCL |
256476-36-5 |
| AZD7545 |
4-[[3-氯-4-[[(2R)-3,3,3-三氟-2-羟基-2-甲基-1-氧代丙基]氨基]苯基]磺酰基]-N,N-二甲基苯甲酰胺 |
252017-04-2 |
| 2,6-PYRIDINEDIAMINE, N6-[2-[[4-(2,4-DICHLOROPHENYL)-5-(1H-IMIDAZOL-1-YL)-2-PYRIMIDINYL]AMINO]ETHYL]-3-NITRO- |
CHIR98014(CT98014) |
252935-94-7 |
| LY411575 |
(AS)-N-[(1S)-2-[[(7S)-6,7-二氢-5-甲基-6-氧代-5H-二苯并[B,D]氮杂卓-7-基]氨基]-1-甲基-2-氧代乙基]-3,5-二氟-ALPHA-羟基苯乙酰胺 |
209984-57-6 |
| Z-DEVD-FMK |
CASPASE-3抑制剂 |
210344-95-9 |
| CB-839 |
CB-839 |
1439399-58-2 |
| N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyraMide |
BMS-5 |
1338247-35-0 |
| ASP-2215 |
吉列替尼 |
1254053-43-4 |
| RQ-00203078 |
4-(N-(3-氯-5-(三氟甲基)吡啶-2-基)-N-(4-(三氟甲氧基)苄基)氨基磺酰基)苯甲酸 |
1254205-52-1 |
| 1-((S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl)-3-((S)-1-(thiophen-3-yl)propan-2-yl)urea |
PZM-21 |
1997387-43-5 |
| EFT-508 |
6'-[(6-氨基-4-嘧啶基)氨基]-8'-甲基螺[环己烷-1,3'(2'H)-咪唑并[1,5-A]吡啶]-1',5'-二酮 |
1849590-01-7 |
| BLU-285 |
阿伐普替尼 |
1703793-34-3 |
| AZD3264 |
AZD3264 |
1609281-86-8 |
| 5-(4-aMino-1-isopropyl-1H-pyrazolo[3,4-d]pyriMidin-3-yl)benzo[d]oxazol-2-aMine |
3-(2-氨基-5-苯并恶唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺 |
1224844-38-5 |
| TPPU |
CS-2462 |
1222780-33-7 |
| (R)-2-(2-methoxyphenyl)-2-((tetrahydro-2H-pyran-4-yl)oxy)ethan-1-ol |
ND-646中间体 |
1434652-66-0 |
